Search for a trial

1 results

A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Darvadstrocel in
the Treatment of Complex Perianal Fistula in Pediatric Subjects with Crohn's Disease over a
Period of 24 Weeks and an Extended Follow-up Period for a Total of up to 52 Weeks.

Approved WMOPending

This study has been transitioned to CTIS with ID 2023-503973-39-00 check the CTIS register for the current data. To evaluate the efficacy of darvadstrocel in combined remission at Week 24 for the treatment of complex perianal fistula in pediatric…

A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with Crohn's Disease over a Period of 24 Weeks and an Extended Follow-up Period for a Total of up to 52 Weeks.

A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Darvadstrocel in
the Treatment of Complex Perianal Fistula in Pediatric Subjects with Crohn's Disease over a
Period of 24 Weeks and an Extended Follow-up Period for a Total of up to 52 Weeks.